Werewolf Therapeutics, Inc.
HOWL
$0.86
-$0.06-6.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.71M | 77.60M | 92.04M | 111.00M | 122.83M |
| Total Receivables | -- | -- | -- | -- | 464.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.46M | 2.84M | 2.42M | 2.07M | 2.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 68.17M | 80.44M | 94.46M | 113.07M | 125.84M |
|
|
|||||
| Total Current Assets | 68.17M | 80.44M | 94.46M | 113.07M | 125.84M |
| Net Property, Plant & Equipment | 10.51M | 11.11M | 11.71M | 12.32M | 12.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 944.00K | 1.02M | 1.07M | 1.54M | 1.26M |
| Total Assets | 79.63M | 92.57M | 107.24M | 126.93M | 140.04M |
|
|
|||||
| Total Accounts Payable | 1.08M | 2.77M | 986.00K | 3.04M | 1.24M |
| Total Accrued Expenses | 8.89M | 8.36M | 9.02M | 10.23M | 9.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.50M | 3.85M | 1.41M | 1.56M | 1.32M |
| Total Finance Division Other Current Liabilities | 133.00K | 182.00K | 249.00K | 356.00K | 451.00K |
| Total Other Current Liabilities | 133.00K | 182.00K | 249.00K | 356.00K | 451.00K |
| Total Current Liabilities | 17.60M | 15.17M | 11.67M | 15.18M | 12.46M |
|
|
|||||
| Total Current Liabilities | 17.60M | 15.17M | 11.67M | 15.18M | 12.46M |
| Long-Term Debt | 21.66M | 24.71M | 26.59M | 26.10M | 25.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.14M | 8.59M | 9.02M | 9.44M | 9.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.61M | 2.64M | 2.66M | 2.83M | 2.74M |
| Total Liabilities | 50.01M | 51.10M | 49.93M | 53.54M | 50.66M |
|
|
|||||
| Common Stock & APIC | 496.64M | 492.12M | 489.98M | 487.98M | 483.57M |
| Retained Earnings | -467.03M | -450.66M | -432.68M | -414.59M | -394.19M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 29.61M | 41.46M | 57.31M | 73.39M | 89.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.61M | 41.46M | 57.31M | 73.39M | 89.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.61M | 41.46M | 57.31M | 73.39M | 89.38M |
|
|
|||||